Ankur Pharmaceuticals Private Limited
About Ankur Pharmaceuticals Private Limited
Data last updated:
Ankur Pharmaceuticals Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 October 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24231UP1986PTC008301. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.25 Lakh. It is led by directors including Shivani Bvhargava and Sandeep Bhargava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 15/295 – C Civil Lines, Kanpur, Uttar Pradesh, India – 208001.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.13 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹8.73 Lakh (net margin 45.6%) and EBITDA of ₹8.73 Lakh (EBITDA margin 45.6%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years and 40% over five years.
As per MCA filings, the company has satisfied charges of ₹15 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ankur Pharmaceuticals Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address15/295 – C Civil Lines, Kanpur, Uttar Pradesh, India – 208001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ankur Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ankur Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ankur Pharmaceuticals Private Limited, buy the company report.
Financials of Ankur Pharmaceuticals Private Limited
FY 2025 filings availableAnkur Pharmaceuticals Private Limited reported revenue of ₹19.13 Lakh (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 14% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 40%. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.73 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.73 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 45.6% | ||||
| Net Profit Margin | 45.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ankur Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ankur Pharmaceuticals Private Limited
Ankur Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivani Bvhargava Also directs: Ugma Laboratories Private Limited | Director | 31 Oct 1998 | 27 Years 11 Months | Current |
| Sandeep Bhargava Also directs: Ugma Laboratories Private Limited | Additional Director | 10 May 2021 | 5 Years 5 Months | Current |
| Nupur Bhargava | Additional Director | 14 Jul 2025 | 1 Years 3 Months | Current |
Auditor
Ankur Pharmaceuticals Private Limited is audited by PRADEEP AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRADEEP AND ASSOCIATES | FY 2017 | 070492 |
Shareholding
The shareholding of Ankur Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ankur Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Mar 2004 | 90270772 | Icici Hfc Ltd. | ₹15 Lakh | Satisfied |
To see the full charge records of Ankur Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ankur Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ankur Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ankur Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Ankur Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ankur Pharmaceuticals Private Limited has 8 board changes on record since 1998: 3 appointments and 5 cessations. The latest: Madhu Bhargava ceased to be Director on 14 Jul 2025.
1 earlier event is in the company report.
Frequently asked questions
Ankur Pharmaceuticals is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 October 1986 (40+ years old) and is registered under CIN U24231UP1986PTC008301.
Ankur Pharmaceuticals has 3 current directors:
- Shivani Bvhargava - Director
- Sandeep Bhargava - Additional Director
- Nupur Bhargava - Additional Director
The latest financial statements of Ankur Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Ankur Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Ankur Pharmaceuticals is U24231UP1986PTC008301. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ankur Pharmaceuticals was incorporated on 22 October 1986, making it 40+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Madhu Bhargava ceased to be Director on 14 Jul 2025. Nupur Bhargava was appointed as Additional Director on 14 Jul 2025. Sandeep Bhargava was appointed as Additional Director on 10 May 2021. Ankur Pharmaceuticals has 8 board changes on record in total.
The registered office of Ankur Pharmaceuticals is at 15295 – C Civil Lines, Kanpur, Uttar Pradesh, India – 208001.
Ankur Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Ankur Pharmaceuticals has no open charges and satisfied charges of ₹15 Lakh as per latest MCA filings.